A Phase Ib Study of HW211026 Ointment in Patients With Actinic Keratosis.

NCT07318675 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

40

Enrollment

INDUSTRY

Sponsor class

Conditions

Actinic Keratosis (AK)

Interventions

DRUG: HW211026
DRUG: Placebo

Sponsor

Hubei Bio-Pharmaceutical Industrial Technological Institute Inc.